Osteoblast-secreted BMP2, in turn, was found to activate the AKT/NFKB axis in prostate cancer cells, leading to enhanced migration of the cells via an activation of the transmembrane adhesion receptors integrin β1 and β3 [111]. This evidence concerns the gene BMP2 and prostate cancer.